Showing results (1-10 of 297) with videos related to
Sort By:
Pageof 30
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 9, 2013
Design considerations for dose-expansion cohorts in phase I trialsAlexia Iasonos, John O'QuigleyBritish Journal of Cancer|June 11, 2021
Randomised Phase 1 clinical trials in oncologyAlexia Iasonos, John O'QuigleyStatistics in Medicine|August 16, 2012
Interplay of priors and skeletons in two-stage continual reassessment methodAlexia Iasonos, John O'QuigleyJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2014
Adaptive dose-finding studies: a review of model-guided phase I clinical trialsAlexia Iasonos, John O'QuigleyJournal of the Royal Statistical Society. Series C, Applied Statistics|November 1, 2017
Phase I Designs that Allow for Uncertainty in the Attribution of Adverse EventsAlexia Iasonos, John O'QuigleyStatistics in Medicine|February 9, 2016
Sequential monitoring of Phase I dose expansion cohortsAlexia Iasonos, John O'QuigleyStatistics in Biopharmaceutical Research|July 30, 2014
Bridging Solutions in Dose Finding ProblemsJohn O'Quigley, Alexia IasonosContemporary Clinical Trials|July 10, 2016
Integrating the escalation and dose expansion studies into a unified Phase I clinical trialAlexia Iasonos, John O'QuigleyStatistics in Biopharmaceutical Research|August 13, 2016
Dose expansion cohorts in Phase I trialsAlexia Iasonos, John O'QuigleyClinical Trials (London, England)|August 13, 2011
Incorporating lower grade toxicity information into dose finding designsAlexia Iasonos, Sarah Zohar, John O'QuigleyPageof 30